Authors | Yann Godbert, Bénédicte Henriques de Figueiredo, Françoise Bonichon, Frédéric Chibon, Isabelle Hostein, Gaëlle Pérot, Camille Dupin, Agnès Daubech, Genevieve Belleannée, Audrey Gros, Antoine Italiano, Isabelle Soubeyran |
Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(J Clin Oncol)
Vol. 33
Issue 20
Pg. e84-7
(Jul 10 2015)
ISSN: 1527-7755 [Electronic] United States |
PMID | 24687827
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Biomarkers, Tumor
- Protein Kinase Inhibitors
- Pyrazoles
- Pyridines
- Crizotinib
- ALK protein, human
- Anaplastic Lymphoma Kinase
- Receptor Protein-Tyrosine Kinases
|
Topics |
- Aged
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents
(therapeutic use)
- Biomarkers, Tumor
(genetics)
- Biopsy
- Chemotherapy, Adjuvant
- Crizotinib
- Female
- Gene Rearrangement
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Lung Neoplasms
(drug therapy, enzymology, genetics, secondary)
- Neoplasm Staging
- Precision Medicine
- Predictive Value of Tests
- Protein Kinase Inhibitors
(therapeutic use)
- Pyrazoles
(therapeutic use)
- Pyridines
(therapeutic use)
- Receptor Protein-Tyrosine Kinases
(antagonists & inhibitors, genetics)
- Remission Induction
- Thyroid Carcinoma, Anaplastic
(drug therapy, enzymology, genetics, secondary)
- Thyroid Neoplasms
(drug therapy, enzymology, genetics, pathology)
- Thyroidectomy
- Time Factors
- Tomography, X-Ray Computed
- Treatment Outcome
|